Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Featured
Off
Source
Bonaca MP, Catarig AM, Houlind K, et al. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet. 2025;405(10489):1580-1593. doi:10.1016/S0140-6736(25)00509-4
Thumbnail
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
STRIDE Trial assessed whether semaglutide enhances walking ability, symptoms, quality of life, and clinical outcomes in individuals with peripheral artery disease and type 2 diabetes.
User Segments
Release Date
Featured Order
0
Is Paid
0